| Literature DB >> 33585727 |
Emily A Eshraghian1, Wael K Al-Delaimy1.
Abstract
INTRODUCTION: Identification of chemicals present in e-liquids and aerosols is a vital first step in assessing the human health effects of e-cigarettes. We aim to identify the qualitative and quantitative constituents present in e-cigarette liquids and aerosols.Entities:
Keywords: aerosols; constituents; e-cigarette; e-liquid; toxicology; vape
Year: 2021 PMID: 33585727 PMCID: PMC7873740 DOI: 10.18332/tpc/131111
Source DB: PubMed Journal: Tob Prev Cessat ISSN: 2459-3087
Constituents identified in e-cigarette liquids (for constituents to be listed, the chemical must have been present in 50% of samples in at least one study)
| Beauval (2017) | 3/6 | 0.20 ng/mL | |
| Han (2016) | 7/55 | N/A | |
| Beauval (2017) | 4/6 | 0.02 ng/mL | |
| Han (2016) | 4/55 | N/A | |
| Farsalinos, Gillman (2015) | 10/21 | 0.12 μg/mL | |
| Han (2016) | 54/55 | N/A | |
| LeBouf (2018) | 89/146 | 106 ppb | |
| Sleiman (2016) | 3/3 | N/A | |
| Varlet (2015) | 42/42 | 0.03 μg/g | |
| Sleiman (2016) | 3/3 | N/A | |
| Han (2016) | 52/55 | N/A | |
| LeBouf (2018) | 74/146 | 275 ppb | |
| Sleiman (2016) | 3/3 | N/A | |
| Varlet (2015) | 2/42 | N/A | |
| Beauval (2017) | 6/6 | 4.0 ng/mL | |
| Famele (2017) | 58/95 | 1.6 μg/m³ | |
| Han (2016) | 43/55 | N/A | |
| Hutzler (2014) | 1/28 | N/A | |
| Lisko (2015) | 30/36 | N/A | |
| Famele (2017) | 58/95 | 0.2 μg/m³ | |
| Han (2016) | 42/55 | N/A | |
| Hutzler (2014) | 2/28 | N/A | |
| Lisko (2015) | 30/36 | N/A | |
| Beauval (2017) | 6/6 | 0.1 ng/mL | |
| Czoli (2019) | 36/166 | N/A | |
| Han (2016) | 3/55 | N/A | |
| Hutzler (2014) | 4/28 | N/A | |
| LeBouf (2018) | 18/146 | N/A | |
| Tierney (2015) | 3/30 | N/A | |
| Varlet (2015) | 30/42 | 0.035 μg/g | |
| Han (2016) | 55/55 | N/A | |
| LeBouf (2018) | 20/146 | 102 ppb | |
| Wagner (2018) | 0/13 | 0.7 ng/g | |
| Lisko (2017) | 25/44 | 0.04 μg/g | |
| Beauval (2017) | 3/6 | 20 pg/mL | |
| Beauval (2017) | 6/6 | 3.7 ng/mL | |
| Kamilari (2018) | 21/22 | N/A | |
| Beauval (2017) | 3/6 | 0.02 ng/mL | |
| Han (2016) | 13/55 | N/A | |
| Beauval (2017) | 3/6 | 20 ng/mL | |
| Kamilari (2018) | 22/22 | N/A | |
| Famele (2017) | 58/95 | 0.1 μg/m³ | |
| Han (2016) | 20/55 | N/A | |
| Farsalinos, Kistler (2015) | 110/159 | N/A | |
| Lebouf (2018) | 67/146 | 102 ppb | |
| Varlet (2015) | 3/42 | N/A | |
| LeBouf (2018) | 139/146 | 225 ppb | |
| Peace (2017) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Varlet (2015) | 30/42 | N/A | |
| Han (2016) | 43/55 | N/A | |
| LeBouf (2018) | 3/146 | 138 ppb | |
| LeBouf (2018) | 91/146 | N/A | |
| Peace (2017) | 1/3 | N/A | |
| Czoli (2019) | 31/166 | N/A | |
| Girvalaki (2018) | 44/122 | N/A | |
| Hutzler (2014) | 16/28 | N/A | |
| Peace (2017) | 1/3 | N/A | |
| Tierney (2015) | 10/30 | N/A | |
| Czoli (2019) | 37/166 | N/A | |
| Girvalaki (2018) | 22/122 | N/A | |
| Hahn (2014) | 13/54 | 1.0 mg/L | |
| Hutzler (2014) | 14/28 | N/A | |
| Tierney (2015) | 10/30 | N/A | |
| Hahn (2014) | N/A | 0.17 mg/L | |
| Varlet (2015) | 31/46 | N/A | |
| Beauval (2017) | 4/6 | 0.05 ng/mL | |
| Han (2016) | 13/55 | N/A | |
| Beauval (2017) | 5/6 | 0.2 ng/mL | |
| Han (2016) | 5/55 | N/A | |
| Farsalinos, Gillman (2015) | 20/21 | 0.12 μg/mL | |
| Han (2016) | 55/55 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Varlet (2015) | 42/42 | 0.06 μg/g | |
| Beauval (2017) | 6/6 | 12.5 mg/mL | |
| Hahn (2014) | 54/54 | 2.6 mg/L | |
| Han (2016) | 55/55 | N/A | |
| Peace (2017) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Lisko (2015) | 30/36 | N/A | |
| Sleiman (2016) | 2/3 | N/A | |
| LeBouf (2018) | 75/146 | 189 ppb | |
| Kamilari (2018) | 22/22 | N/A | |
| Hutzler (2014) | 2/28 | N/A | |
| LeBouf (2018) | 79/146 | 275 ppb | |
| Peace (2017) | 3/3 | N/A | |
| Han (2017) | 55/55 | N/A | |
| LeBouf (2018) | 16/146 | 114 ppb | |
| Famele (2017) | 58/95 | 0.1 μg/m³ | |
| Han (2016) | 42/55 | N/A | |
| Hutzler (2014) | 2/28 | N/A | |
| Lisko (2015) | 30/36 | N/A | |
| Han (2016) | 43/55 | N/A | |
| Beauval (2017) | 5/6 | 0.2 ng/mL | |
| Han (2016) | 12/55 | N/A | |
| Kamilari (2018) | 21/22 | N/A | |
| Beauval (2017) | 3/6 | 2.0 mg/mL | |
| Hahn (2014) | 34/54 | 1.6 mg/L | |
| Han (2016) | 52/55 | N/A | |
| Lisko (2015) | 29/26 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Famele (2017) | 58/95 | 0.1 μg/m³ | |
| Farsalinos, Gillman (2015) | 11/21 | 2.5 μg/mL | |
| Farsalinos, Gillman (2015) | 21/21 | 1 ng/mL | |
| Han (2016) | 2/55 | N/A | |
| Farsalinos, Gillman (2015) | 12/21 | 1 ng/mL | |
| Lisko (2015) | 30/36 | N/A | |
| Han (2016) | 51/55 | N/A | |
| LeBouf (2018) | 6/146 | 102 ppb | |
| Beauval (2017) | 6/6 | 31.25 mg/mL | |
| Hahn (2014) | 54/54 | 2.1 mg/L | |
| Han (2016) | 55/55 | N/A | |
| Peace (2017) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Beauval (2017) | 6/6 | 0.2 ng/mL | |
| Han (2016) | 7/55 | N/A | |
| Farsalinos, Gillman (2015) | 1/21 | 0.05 μg/mL | |
| Han (2016) | 40/55 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Peace (2017) | 2/3 | N/A | |
| Peace (2017) | 3/3 | N/A | |
| Han (2016) | 32/55 | N/A | |
| LeBouf (2016) | 13/146 | 126 ppb | |
| Wagner (2018) | 0/13 | 0.7 ng/g | |
| Czoli (2019) | 36/166 | N/A | |
| Hutlzer (2014) | 22/28 | N/A | |
| Sleiman (2016) | 1/3 | N/A | |
| Tierney (2015) | 15/30 | N/A | |
| Hutzler (2014) | 1/28 | N/A | |
| Sleiman (2016) | 2/3 | N/A | |
| Girvalaki (2018) | 23/122 | N/A | |
| Tierney (2015) | 1/30 | N/A | |
| Famele (2017) | 58/95 | 0.2 μg/m³ | |
| Czoli (2019) | 115/166 | N/A | |
| Czoli (2019) | 104/166 | N/A | |
| Hutzler (2014) | 1/28 | N/A | |
| Sleiman (2016) | 1/3 | N/A | |
| Tierney (2015) | 1/30 | N/A |
Constituent presence in liquid and aerosol. LOD: limit of detection. LOQ: limit of quantitation. NAB: N'-Nitrosoanabasine. NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. NNN: N-Nitrosonornicotine. PAH: polycyclic aromatic hydrocarbon. PG: propylene glycol. VG: vegetable glycerin.
Constituents identified in e-cigarette aerosols (for constituents to be listed, the chemical must have been present in 50% of samples in at least one study)
| Beauval (2017) | 6/6 | 0.09 pg/mL puff | |
| Beauval (2017) | 6/6 | 0.05 pg/mL puff | |
| Bekki (2014) | 9/13 | N/A | |
| Goniewicz (2013) | 12/12 | N/A | |
| Klager (2017) | 26/26 | 27.3 μg/m³ | |
| Peace (2018) | 1/4 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Allen (2016) | 46/51 | 0.05 μg/sample | |
| Klager (2017) | 17/26 | 0.00 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Farsalinos, Kistler (2015) | 3/3 | N/A | |
| Beauval (2017) | 4/6 | 0.05 ng/mL puff | |
| Bekki (2014) | 9/13 | N/A | |
| Goniewicz (2013) | 10/12 | N/A | |
| Peace (2018) | 1/4 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Beauval (2017) | 4/6 | 0.11 pg/mL puff | |
| Klager (2017) | 17/26 | 9.81 μg/m³ | |
| Kosmider (2016) | 108/145 | 0.025 μg/30 puffs | |
| Peace (2018) | 1/4 | N/A | |
| Sleiman (2016) | 2/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Wagner (2018) | 0/19 | 3.2 μg/g | |
| Sleiman (2016) | 2/3 | N/A | |
| Beauval (2017) | 2/6 | 0.025 μg/30 puffs | |
| Goniewicz (2013) | 11/12 | N/A | |
| Beauval (2017) | 3/6 | 2.1 pg/mL puff | |
| Halstead (2019) | 9/17 | 0.125 ng/10 puffs | |
| Williams (2013) | N/A | N/A | |
| Halstead (2019) | 12/17 | 0.20 ng/10 puffs | |
| Williams (2013) | N/A | N/A | |
| Klager (2017) | 4/26 | 0 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Schripp (2013) | 3/3 | N/A | |
| Allen (2016) | 39/51 | 0.05 μg/sample | |
| Farsalinos, Kistler (2015) | 3/3 | N/A | |
| Klager (2017) | 16/26 | 0.00 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Peace (2018) | 4/4 | N/A | |
| Beauval (2017) | 6/6 | 0.05 pg/mL puff | |
| Bekki (2014) | 9/13 | N/A | |
| Goniewicz (2013) | 12/12 | N/A | |
| Klager (2017) | 24/26 | 5.77 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Beauval (2017) | 6/6 | 3.4 μg/mL puff | |
| Peace (2018) | 3/4 | N/A | |
| Schripp (2013) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Bekki (2014) | 8/13 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Klager (2017) | 13/26 | 0.00 μg/m³ | |
| Beauval (2017) | 4/6 | 0.23 pg/mL puff | |
| Goniewicz (2013) | 12/12 | N/A | |
| Halstead (2019) | 8/17 | 0.05 ng/10 puffs | |
| Williams (2013) | N/A | N/A | |
| Peace (2018) | 2/4 | N/A | |
| Sleiman (2016) | 2/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Bekki (2014) | 8/13 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Beauval (2017) | 6/6 | 0.47 pg/mL puff | |
| Goniewicz (2013) | 12/12 | N/A | |
| Halstead (2019) | 14/17 | 0.250 ng/10 puffs | |
| Williams (2013) | N/A | N/A | |
| Beauval (2017) | 3/6 | 0.0038 μg/mL puff | |
| Czogala (2013) | 12/12 | 0.22 μg/m³ | |
| Famele (2017) | 7/13 | 0.1 μg/m³ | |
| Peace (2018) | 4/4 | 10 ng/mL | |
| Schripp (2013) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Famele (2017) | 7/13 | 0.1 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Goniewicz (2013) | 9/12 | N/A | |
| Goniewicz (2013) | 9/12 | N/A | |
| Goniewicz (2013) | 12/12 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Goniewicz (2013) | 10/12 | N/A | |
| Beauval (2017) | 6/6 | 3.0 μg/mL puff | |
| Peace (2018) | 4/4 | N/A | |
| Schripp (2013) | 3/3 | N/A | |
| Bekki (2014) | 8/13 | N/A | |
| Klager (2017) | 23/26 | 1.2 μg/m³ | |
| Sleiman (2016) | 3/3 | N/A | |
| Halstead (2019) | 10/17 | 0.10 ng/10 puffs | |
| Goniewicz (2013) | 10/12 | N/A | |
| Wagner (2018) | 0/19 | 3.2 μg/g | |
| Sleiman (2016) | 3/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Sleiman (2016) | 2/3 | N/A | |
| Sleiman (2016) | 3/3 | N/A | |
| Schripp (2013) | 3/3 | N/A |
Constituent presence in liquid and aerosol. LOD: limit of detection. LOQ: limit of quantitation. NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. NNN: N-Nitrosonornicotine. PAH: polycyclic aromatic hydrocarbon. PG: propylene glycol. VG: vegetable glycerin.
Laboratory analysis methods for identification and quantitation of e-cigarette liquids
| Beauval (2017) | GC-MS-MS |
| Czoli (2019) | UPLC-MS-MS |
| Famele (2017) | LC-MS-MS |
| Farsalinos, Gillman (2015) | GC |
| Farsalinos, Kistler (2015) | FID-GC |
| Girvalaki (2018) | GC-MS |
| Hahn (2014) | NMR spectroscopy |
| Han (2016) | GC-FID |
| Hutzler (2014) | GC-MS |
| Kamilari (2018) | Total reflection X-ray fluorescence spectrometry |
| LeBouf (2018) | HS-GC-MS |
| Lisko (2015) | GC-MS-MS |
| Lisko (2017) | GC-MS |
| Peace (2017) | DART-MS |
| Sleiman (2016) | HS-GC-MS |
| Tierney (2015) | GC-MS |
| Varlet (2015) | GC-MS |
| Wagner (2018) | GC-MS |
DART-MS: direct analysis in real time mass spectroscopy. GC: gas chromatography. GC-FID: gas chromatography with flame ionization detector. GC-MS: gas chromatography-mass spectrometry. GC-MS-MS: gas chromatography with tandem mass spectrometry. HPLC: high performance liquid chromatography. HPLC-DAD: high performance liquid chromatography with diode-array detector. HPLC-FLD: high performance liquid chromatography with fluorescence detector. HPLC-MS-MS: high performance liquid chromatography with tandem mass spectrometry. HPLC-UV: high performance liquid chromatography with ultraviolet radiation. HS-GC-FID: headspace gas chromatography with flame ionization detector. ICP-MS: inductively coupled plasma mass spectrometry. HS-FID: headspace with flame ionization detector. HS-GC-MS: headspace gas chromatography with mass spectrometry. LC-MS: liquid chromatography-mass spectrometry. LC-MS-MS: liquid chromatography with tandem mass spectrometry. LC-UV-MS: liquid chromatography with ultraviolet radiation and mass spectrometry. NMR: nuclear magnetic resonance. UPLC: ultra-performance liquid chromatography.
Laboratory analysis methods for identification and quantitation of e-cigarette aerosols
| Allen (2016) | GC-ECD |
| Beauval (2017) | GC-MS-MS |
| Bekki (2014) | HPLC |
| Czogala (2013) | GC-NPD |
| Famele (2017) | LC-MS-MS |
| Farsalinos, Kistler (2015) | HPLC |
| Goniewicz (2013) | HPLC-DAD |
| Halstead (2019) | MS-MS |
| Klager (2017) | HPLC-UV |
| Kosmider (2016) | HPLC |
| Peace (2018) | HPLC-MS |
| Schripp (2013) | Thermal desorption |
| Sleiman (2016) | HS-GC-MS |
| Wagner (2018) | GC-NCI MS |
| Williams (2013) | ICP-OES |
DART-MS: data analysis in real time-mass spectrometry. EDXS: energy dispersive x-ray spectroscopy. GC: gas chromatography. GC-ECD: gas chromatography with electron capture detector. GC-FID: gas chromatography with flame ionization detector. GC-MS: gas chromatography-mass spectrometry. GC-MS-MS: gas chromatography with tandem mass spectroscopy. GC-NCI MS: gas chromatography-negative chemical ionization mass spectrometry. GC-NPD: gas chromatography with nitrogen phosphorous detector. HPLC: high performance liquid chromatography. HPLC-DAD: high performance liquid chromatography with diode-array detector.
HPLC-UV: high performance liquid chromatography with ultraviolet radiation. HS-GC-MS: headspace gas chromatography with mass spectrometry. ICP-MS: inductively coupled plasma mass spectrometry. ICP-OES: inductively coupled plasma atomic emission spectroscopy. ICP-UV-MS: inductively coupled plasma with ultraviolet radiation and mass spectrometry. LC-MS-MS: liquid chromatography with tandem mass spectrometry. OSHA: Occupational Safety and Health Administration. SEM: scanning electron microscope. TD-GS-MS: thermal desorption coupled with gas chromatography mass spectrometry. UPLC-MS: ultra-performance liquid chromatography-mass spectrometry. UPLC-MS-MS: ultra-performance liquid chromatography with tandem mass spectrometry.